Aprogen Healthcare Valuation

109960 Stock  KRW 475.00  12.00  2.46%   
At this time, the firm appears to be overvalued. Aprogen Healthcare Games shows a prevailing Real Value of W448.77 per share. The current price of the firm is W475.0. Our model approximates the value of Aprogen Healthcare Games from analyzing the firm fundamentals such as Return On Equity of 3.02, current valuation of 126 B, and Profit Margin of 0.17 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
475.00
Please note that Aprogen Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Aprogen Healthcare Games is based on 3 months time horizon. Increasing Aprogen Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aprogen Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aprogen Stock. However, Aprogen Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  475.0 Real  448.77 Hype  475.0 Naive  484.12
The real value of Aprogen Stock, also known as its intrinsic value, is the underlying worth of Aprogen Healthcare Games Company, which is reflected in its stock price. It is based on Aprogen Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aprogen Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
445.86
Downside
448.77
Real Value
522.50
Upside
Estimating the potential upside or downside of Aprogen Healthcare Games helps investors to forecast how Aprogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aprogen Healthcare more accurately as focusing exclusively on Aprogen Healthcare's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
467.69479.00490.31
Details
Hype
Prediction
LowEstimatedHigh
472.09475.00477.91
Details
Naive
Forecast
LowNext ValueHigh
481.20484.12487.03
Details

Aprogen Healthcare Total Value Analysis

Aprogen Healthcare Games is presently forecasted to have takeover price of 126 B with market capitalization of 54.14 B, debt of 37.5 M, and cash on hands of 11.53 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aprogen Healthcare fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
126 B
54.14 B
37.5 M
11.53 B

Aprogen Healthcare Investor Information

About 60.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Aprogen Healthcare Games had 2:1 split on the 15th of June 2018. Based on the measurements of operating efficiency obtained from Aprogen Healthcare's historical financial statements, Aprogen Healthcare Games is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

Aprogen Healthcare Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Aprogen suggests not a very effective usage of assets in November.

Aprogen Healthcare Ownership Allocation

Aprogen Healthcare holds a total of 178.7 Million outstanding shares. Aprogen Healthcare Games retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Aprogen Healthcare Profitability Analysis

The company reported the revenue of 8.42 B. Net Income was 2.65 B with profit before overhead, payroll, taxes, and interest of 2.46 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aprogen Healthcare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aprogen Healthcare and how it compares across the competition.

About Aprogen Healthcare Valuation

The stock valuation mechanism determines Aprogen Healthcare's current worth on a weekly basis. Our valuation model uses a comparative analysis of Aprogen Healthcare. We calculate exposure to Aprogen Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aprogen Healthcare's related companies.
Aprogen Healthcare Games Inc. engages in the development of medicines using biomedical technology. Aprogen Healthcare Games Inc. was founded in 1998 and is headquartered in Seongnam, South Korea. Aprogen HG is traded on Korean Securities Dealers Automated Quotations in South Korea.

8 Steps to conduct Aprogen Healthcare's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Aprogen Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Aprogen Healthcare's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Aprogen Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Aprogen Healthcare's revenue streams: Identify Aprogen Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Aprogen Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Aprogen Healthcare's growth potential: Evaluate Aprogen Healthcare's management, business model, and growth potential.
  • Determine Aprogen Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Aprogen Healthcare's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Aprogen Stock analysis

When running Aprogen Healthcare's price analysis, check to measure Aprogen Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aprogen Healthcare is operating at the current time. Most of Aprogen Healthcare's value examination focuses on studying past and present price action to predict the probability of Aprogen Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aprogen Healthcare's price. Additionally, you may evaluate how the addition of Aprogen Healthcare to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Transaction History
View history of all your transactions and understand their impact on performance